Improving treatment outcomes for patients across Canada
University of Toronto professor Paul Saneterre is a chemical engineer and co-founder of the Toronto-based health technologies company Interface Biologics Inc. He invented Endexo technology, a unique compound of surface-modifying macro molecules that are added to plastics during the manufacturing process of medical devices, like catheters. The special coating helps reduce clotting when the devices are used to treat patients, reducing the risk of adverse reactions and potentially deadly complications. Mr. Santerre is a listed inventor on over 60 patents in the medical field and has received numerous awards including the Manning Award for Innovation/Entrepreneurship and a fellowship with the Canadian Academy of Health Sciences.
*Paul Santerre is a 2017 winner of the Governor General’s Innovation Awards.